To determine the frequency of deliveries to women with a solid organ transplant, and to quantify associated severe maternal morbidity and mortality. STUDY DESIGN: We carried out a retrospective cohort study of all hospital live births at >¼20 weeks' gestation in Canada (excluding Quebec) between 2003 and 2012 with data obtained from the Canadian Institute for Health Information. Severe maternal morbidity was defined both as a composite outcome and also as specific severe maternal morbidity using International Classification of Diseases (ICD-10CA) diagnosis codes and also Interventions codes. Logistic regression was used to obtain adjusted odds ratios (AOR) and 95% confidence intervals (CI) after adjustment for maternal age, parity, plurality, and use of assisted reproduction. RESULTS: There were 3,587,840 deliveries included in the study population of which 296 were to women with a solid organ transplant (8.3 per 100,000). The most common transplant subtypes included kidney and liver transplants. Composite severe maternal morbidity rates were 125.0 (95% CI 88.0-172.3) and 9.4 (95% CI 9.3-9.5) per 1,000, respectively, among women with and without a solid organ transplant. The median length of hospital stay for women with and without a solid organ transplant was 8 and 3 days, respectively, while the frequency of prolonged hospital stay (>7 days) was 22.3% and 1.8%, respectively. Regression analysis showed that women with solid organ transplants had substantially higher rates of composite severe maternal morbidity (AOR 14.6, 95% CI 10.1-21.3). Severe morbidity among women with organ transplants included severe preeclampsia or HELLP syndrome (AOR 5.9, 1.9-18.4), eclampsia (AOR 16.3, 95% CI 5.2-0.9), acute renal failure (AOR 231.3, 95% CI 140.1-381.8), acute fatty liver with red cell or plasma transfusion (AOR 38.5, 95% CI 5.3-277.8), hepatic failure (AOR 154.3, 95% CI 21.3-999.9) and cardiac conditions (Table 1) . CONCLUSION: Severe maternal morbidity and hospitalization patterns show that women with solid organ transplants have serious lifethreatening pregnancy-related challenges. Absolute and relative severe morbidity rates from this study will be useful for formulating standard of care guidelines, and for counselling and managing pregnant women with solid organ transplants. OBJECTIVE: Malaria in pregnancy is associated with adverse perinatal outcomes. The aim was to compare outcomes of simple and severe malaria and whether they vary by trimester of infection. STUDY DESIGN: A prospective cohort study performed over a 10 month period in 3 hospitals in Rwanda. Both hospitalized and nonhospitalized pregnant patients with confirmed malaria were enrolled and followed until 7 days postpartum. Demographic, clinical manifestations and perinatal outcomes were recorded. RESULTS: There were 484 pregnant women with confirmed malaria: 446 had perinatal outcomes and 38 women were lost to follow up. In total, 361 (80.9%) had simple malaria. Patients were predominantly from rural areas (85.4%). Among the patients with severe malaria, 84.7% were rural and 34.5% were primigravidas. Severe anemia (hemoglobin < 7g/dl) and thrombocytopenia (<50K) were present in 11.7% and11.4%. Severe CNS complications were noted in 18 patients (4.04%). Severe malaria was more common as pregnancy progressed; out of 85 with severe malaria, 12.9% were in the 1st, 29.4% in the 2nd and 57.6% in the 3rd trimester (p<0.0001). Overall, a normal term delivery occurred in 59%, with preterm delivery (PTD) in 17.4% and abortion in 13.9%. Adverse perinatal outcomes increased with trimester of infection (p<0.0001) ( Table 1) . Two-thirds of the 9 early neonatal deaths had 3 rd trimester infection (p<0.0001). A significant difference in perinatal outcomes between simple and severe malaria was seen: 65.1% of women with simple malaria had a normal term delivery as compared to 32.9% with severe malaria
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